In an open prospective study, adrenaline administration in ten patients with eleven episodes of septic shock was studied. Appropriate supportive therapy (antibiotics, laparotomies, parenteral alimentation, ventilation) was given as needed. Haemoglobin was kept at or above 12 g%, pulmonary capillary wedge pressure kept at approximately 15 mmHg, and cardiac index at greater than 4.5 IIminlm 2 . Only when systemic vascular resistance (SVR) dropped below 600 dyn. s. cm -5 was adrenaline given to raise the latter to no higher than 800 dyn. s. cm -5 and the adrenaline was titrated to this end point. Adrenaline was used at doses up to 0.47 Jiglkglmin for up to nineteen days. There was no reliable dose response curve for adrenaline: each septic insult needed different dosages. However, if high enough doses were given, SVR eventually increased. There was no deterioration in cardiac index nor further increase in pulse rate and no renal damage was demonstrated. Only one patient died in septic shock. Two others died from causes not directly related to sepsis and another two while still in hospital, but again not septic. Five patients were eventually discharged from hospital. Adrenaline can thus be used as a vasoconstrictor in septic shock without adverse effects, but initial doses have to be high and the effects measured and titrated carefully. Used this way, adrenaline provides time for the eradication of sepsis.
Septic shock is a life-threatening complication of infection. Besides treating the underlying infective process and generally supporting the patient, haemodynamic manipulation is important. Recent work on the syndrome has shown that patients may exhibit cardiac depression,I-3 peripheral vascular failure 4 ,5 and alteration in adrenergic receptor activity.6,7 It is therefore not surprising that the dose of catecholamine needed for any required response is variable. [8] [9] [10] [11] [12] [13] Noradrenaline has recently been used with good haemodynamic effect in hyperdynamic septic shock. 12 -14 Because this is not available in South Africa, we decided to investigate haemodynamic effects, especially the vasoconstrictor effects, of adrenaline in this syndrome, in an open, clinical study. To the best of our knowledge no such data on adrenaline in septic shock is available.
PATIENTS AND METHODS
Our protocol for the treatment of septic shock has been described elsewhere. 15 Briefly we keep arterial oxygen content high by keeping haemoglobin ~12 gm % and P a o 2 > 60 mmHg (normal for this altitude is 75 mmHgI6). To decrease work of breathing and to keep P a o 2 at this level, most of our patients are ventilated. We ventilate with a tidal volume of around 10 mllkg and PEEP of 5 cm H 2 0 so that right ventricular afterload is minimised. 17 ,18 PaC02 is kept within our normal range l6 and the F I o 2 is often high. Cardiac index is maintained at greater than 4.5 I/min/m 2 increasing preload initially, i.e. pulmonary capillary wedge pressure (PCWP) approximately 1 5 mmHg, thereby using the Starling response and at the same time appreciating the pitfalls of using PCWP to reflect left ventricular and diastolic volume. 19 Failing this, inotropic agents are added.
From May 1988 to December 1988 all patients who had septic shock and were hypotensive after adequate fluid and, if appropriate, dobutamine administration (see later) were entered into the study. All patients had to have a hyperdynamic circulation; systolic blood pressure ~95 mmHg, or ~50 mmHg drop in previously recorded blood pressure (after fluids and dobutamine if necessary); decreased organ perfusion (e.g. urine output < 20 mUhr, confusion) and a bacteraemia and/or a focus of infection. All patients were treated with appropriate antibiotics and underwent one or more laparotomies if indicated. All but one of the patients were mechanically ventilated. All received parenteral alimentation and other supportive treatment as indicated. Dopamine was kept constant throughout the study at 2-3 Ilglkglmin for renal protection and daily serum creatinines measured. All patients had daily routine ECGs.
All patients had pulmonary artery catheters (7,5F Swan Ganz VIP catheters) in situ. After calibrating and zeroing the pressure transducer at the mid-axillary line, mean right atrial pressure (RAP), end-expiratory pulmonary artery pressure (PAP) and end-expiratory PCWP were measured on a calibrated oscilloscope. Thermodilution cardiac output measurements were done by means of a COMM 1 cardiac output computer. Measurements were made as frequently as clinically necessary or feasible, anything from halfhourly while the patient was unstable to twelvehourly when the patient was stable. After discarding the first, an average of three cardiac output measurements within 10% of each other, were recorded. Blood pressure was measured noninvasively by means of a Dinamap. Standard formulae were used to calculate cardiac index (Cl), stroke volume (SV), stroke volume index (SVI), systemic vascular resistance (SVR) and left ventricular stroke work index (L VSWI). Preload was increased to keep PCWP about 15 mmHg. If Cl was < 4.5 Umin/m2, dobutamine was added to keep Cl higher than this value. Adrenaline was then added if SVR was < 600 dyn. s. cm -5 to keep SVR 600 to 800 dyn. s. cm -5. While adrenaline was titrated to increase the SVR, dobutamine levels (for the purpose of this study) were kept constant. When an adequate SVR was reached by the adrenaline titration, dobutamine and adrenaline were titrated accordingly for the rest of the septic insult to keep Cl> 4.5 Umin/m 2 . Adrenaline doses (see later) never went higher than these initial doses required to achieve the goal SVR. If after adequate fluid resuscitation, the Cl was> 4.5 Uminlm 2 and SVR < 600 d yn. s. cm -5, adrenaline alone was used to keep Cl > 4.5 I/minlm 2 and SVR 600 to 800 dyn. s. cm- 5 • The vasoactive agents were continued until shock resolved or the patient died.
Statistical analysis
Student's t-test was used to determine the significance of the difference between variables pre-adrenaline and on maximum adrenaline.
RESULTS
Patients' age, sex, Apache 11 scores and infective sites are shown in Table 1 , as are days on adrenaline, maximum adrenaline doses used and patient outcome.
One patient had two episodes of septic shock that needed vasoconstrictor therapy as defined above, and his variables are entered twice (patient 2a, 2b). Note also, his second Apache score was for the 24 hours of his re-admission to the Intensive Care Unit. In four of the eleven episodes of septic shock adrenaline was the only inotropic agent used during the titration of the drug up to its maximal dose.
SVR never dropped below baseline. With enough adrenaline SVR always increased. There was no correlation between dose of adrenaline needed and SVR in absolute numbers, but initially as adrenaline was increased, SVR increased. Later this correlation reversed. Dobutamine was used at some stage of the disease in nine patients.
Although not tabulated here there was no correlation between the dose of dobutamine and maximum adrenaline and no correlation between the dose of dobutamine and SVR.
The maximum doses used in each patient ranged from 0.11 to 0.47 )lglkglmin. The haemodynamic variables prior to adrenaline administration, on maximum adrenaline and, where applicable, once adrenaline had been weaned, are shown in Table 2 .
Adrenaline was used for an average of 7.3 days (range 2-19 days). Survivors were on it for an average of 4.5 days (range 2-7 days), whereas nonsurvivors an average of 10.8 days (range 3-19 days).
Five patients were discharged from hospital. Three died still septic, one from septic shock, one from a technical fault still in septic shock and one from uncontrollable bowel sepsis but not shocked. Two others also died, but after the septic insult had resolved. One died from uncontrollable bowel haemorrhage and the other from respiratory obstruction from a mucous plug, confirmed at post mortem.
We could not document any myocardial damage from the high adrenaline doses or the long duration of adrenaline administration.
DISCUSSION
Adrenaline is an endogenous alpha-and betaadrenergic receptor stimulant. Although texts 2 0-22 state that at lower doses adrenaline acts as a beta-stimulant and at higher doses it has alpha and beta activity, the actual doses for these effects are not uniform.20,21 Greenfield 21 states doses of 0.1-0.4 )lglkglmin 'can increase systolic pressures without raising diastolic BP as a result of peripherally mediated vasodilation'. This is thought to occur simultaneously with myocardial irritability. He also quotes higher doses causing pure alpha vasoconstriction with decreased renal blood flow. 'Added to these effects are renin and angiotensin released by beta stimulation,' 21 We have however shown that the above dosage range for significant vasoconstrictor effects of adrenaline does not refer to patients with septic shock. The required dosages of adrenaline for our haemodynamic goals in this condition varied widely being not dissimilar to doses quoted by Greenfield 21 but higher than those quoted by van der Merwe. 20 This unpredictable response of the cardiovascular system in sepsis to catecholamines has previously been shown with dobutamine and with dopamine. 8 • lo , 13 We have now shown that although SVR will increase if enough adrenaline is used, there is no reliable dose-response curve for adrenaline in sepsis. The drug should be titrated to a required end point. Our end point was to keep Cl greater than 4,5 I/minlm 2 and to raise SVR to no higher than 800 dyn. s. cm -s. Although largely arbitrary end points these figures have been adapted from Shoemaker's work and discussed in more detail by one of us in another text. IS In four of the eleven episodes adrenaline was used alone. We could find no real difference in the haemodynamic effects in this small sample versus the group where dobutamine also was used, As the dosages of dobutamine (used here as the main inotropic agent) and adrenaline (used mainly for its vasoconstrictor properties) vary and do not correlate with each other or with other variables of sepsis, it would seem reasonable to assume that each patient responds differently to the septic insult. The myocardial response also seems to differ from the vascular response in these patients.
Adrenaline, as part of our protocol design, produced an increase in SVR ( Table 2 ). It must be stressed that this desired effect was achieved often only at very high doses of adrenaline. It is worth pointing out that SVR of 800 dyn. s. cm -5 is still lower than 'normal' and other studies have aimed for higher SVRS.Il,12,23 The increased afterload so produced did not cause a significant drop in Cl ( Table 2 ). This was either due to the concomitant beta inotropic effects of adrenaline and/or the concomitant administration of dobutamine. Blood pressure consistently rose with the adrenaline infusion and there was also an increase in LVSWI.
Although we did not specifically look at the renal effects of adrenaline, which would in the presence of ongoing sepsis be difficult to differentiate from the septic insult, serum creatinine levels did not rise with the dosages of adrenaline used. This is not surprising and Desjars et al. 12 report similar findings with noradrenaline. If the septic focus is controlled, the increased renal perfusion pressure produced by adrenaline may in fact help renal function. As 'low' dose dopamine was used prior to, and kept constant throughout the administration of adrenaline, this too may have contributed to the lack of renal side-effects.
The use of high doses of adrenaline did not produce a further increase in pulse rate. No arrhythmia (apart from the original tachycardia) was documented during the study period. No arrhythmia recall or storage system was utilized and therefore we may possibly have missed certain arrhythmias. If so, these were not clinically significant. We could detect no deterioration in any patient that was not attributed to the underlying disease itself.
At low doses, adrenaline could act as a pure beta-agoniseO,21 thereby causing an increase in cardiac output and drop in SVR. We could not demonstrate this in any of our patients, even those not on dobutamine. One possible explanation for this is that the significant vasodilation already present in septic patients prior to starting adrenaline prevented further vasodilation from beta stimulation. Another possible explanation could be the presence of the low-dose dopamine which vasodilates splanchnic vascular beds.
From our study we cannot comment on the recognised inotropic or beta-l effects of adrenaline.
We found no myocardial irritability at similar doses to those quoted by Greenfield 21 and no renal damage. It must be stressed though, that all our patients were on 'low' -dose dopamine (2-3 ~glkgl min) and the lack of renal damage could possibly be attributed to this.
The specific aim of this study was to investigate some of the cardiovascular effects of adrenaline. It would however not be out of place to comment on our mortality rate. Mortality figures in various studies on septic shock are impossible to compare with any meaningful conclusions. There has been no severity index used in any of the studies. Patients' ages, underlying disease processes, duration of shock prior to entry into the study are not controlled. Even the definition of septic shock is not uniform with hypotension often undefined. 1 , 24 We used as our definition of hypotension a systolic BP :::;;95 mmHg, or 50 mmHg or more lower than previously recorded after adequate fluid resuscitation ( Table 2 ) -another factor not controlled in a number of studies. Of the five deaths in this study only two can be directly related to infection, although the septic insult probably contributed to the demise of the other three as they were all well prior to admission.
Even though this study is small, we consider our mortality to be no worse than most of the quoted series for a similar severity of sepsis after adequate fluid resuscitation.
In conclusion, we have shown that adrenaline is an effective vasoconstrictor when used in very high dosages in septic shock. When adrenaline is used as above, SVR will always increase, but there is no reliable dose-response curve, with each patient (and septic insult) needing different doses to achieve the desired end point (ours being Cl > 4.5 Vminlm 2 and SVR 600 to 800 dyn. s. cm -5). Because of abnormal vascular responses, initial doses of adrenaline need to be a lot higher than texts quote and once the sepsis is controlled, the adrenaline can be decreased and ceased. If the above haemodynamic parameters are achieved there is an improvement in the patient's condition with no further renal damage. During this time the sepsis must be eradicated for survival. Adrenaline used in this way may provide time for the control and eradication of sepsis by other means.
